Capital Rx, an enterprise health technology and benefit administration company, has announced a $400 million investment, including a $252 million Series F funding round. Concurrent with this funding, the company is rebranding as Judi Health to reflect its expanded capabilities as a full-service health benefits technology company. The move addresses inefficiencies in health benefits administration and the rising cost of U.S. healthcare, projected to increase nearly 9% in 2026. Joshua Sommerfeld, Healthcare Sector Lead at Wellington Management, said, "By combining a transparent PBM model with a scalable, AI-powered platform, they're building the infrastructure for the next generation of health benefit administration."
Founded in 2017 by CEO AJ Loiacono and CTO Ryan Kelly, Judi Health manages over 4 million employer PBM members and 54 million health plan lives. Its offerings include Capital Rx, a transparent PBM; Judi Health, a full-service benefits platform integrating pharmacy, medical, vision, and dental benefits; and Judi, a scalable SaaS solution for unified claims administration. Holly Maloney, Managing Director at General Catalyst, said, "Their leadership in transparent PBM and their vision to unify pharmacy and medical benefits represent a transformative shift in healthcare administration." AJ Loiacono added, "Judi Health is not just the promise of better care; it is the technology that powers the future of U.S. healthcare." The funding will accelerate the deployment of Judi Health’s Enterprise Health Platform across pharmacy and full health benefits management.
